service / Stem-cell
Using mesenchymal stem cells from bone marrow aspirate concentrate,
we care for the recovery and regenerative environment.
Why Lisoom
Bone marrow stem cell treatment is a regenerative treatment that harvests and uses mesenchymal stem cells (BMSCs) from bone marrow, the longest-studied source of stem cells in the human body.
When the harvested bone marrow is concentrated and purified into bone marrow aspirate concentrate (BMAC), it contains stem cells together with several components involved in regeneration. BMSCs are known to have the capacity for self-renewal and the multilineage potential to differentiate into bone, cartilage, fat, and other tissues.
RESUM Plastic Surgery does not overstate stem cell regeneration and explains both the significance and the limitations of autologous cell-based treatment.
Bone marrow stem cell treatment is a regenerative treatment in which mesenchymal stem cells (BMSCs) are harvested from bone marrow, the longest-studied source in the human body, and purified into bone marrow aspirate concentrate (BMAC) for use.
DESIGN PRINCIPLE
Autologous cells are harvested from bone marrow, a source that has long been studied in the human body. Because your own bone marrow is used, the risk of rejection tends to be low, and hygiene and safety are prioritized throughout the harvesting process.
When the harvested bone marrow is concentrated by centrifugation or similar methods, bone marrow aspirate concentrate (BMAC) with a high density of stem cells can be obtained. It contains BMSCs together with a variety of regeneration-related components.
Mesenchymal stem cells (BMSCs) are known to have the capacity for self-renewal and the multilineage potential to differentiate into bone, cartilage, fat, and other tissues, and they are a source with a long record of clinical research data.
The purified bone marrow aspirate concentrate is precisely injected into the target area. Results tend to appear gradually over 4-12 weeks as regeneration progresses.
Column
This is general medical information intended to help you understand research findings on PRP and PRF skin treatments. The results of the studies cited do not guarantee individual outcomes, and whether to have treatment, the method, and the number of sessions depend on an examination and your health condition. Sources were checked on October 1, 2026. Generated images are for illustration only and are not actual patients, equipment, specimens, microscope photographs, or treatment results.
Learn More
OUR PRINCIPLE
Use of Bone Marrow Aspirate Concentrate (BMAC)
When bone marrow is harvested and concentrated by centrifugation or similar methods, bone marrow aspirate concentrate (BMAC) with a high density of stem cells can be obtained. It contains BMSCs together with a variety of regeneration-related components. BMSCs are known to have multilineage differentiation potential and a long record of clinical research data, and they are used to address recovery of relatively deep tissue environments.
Autologous Cell-Based Approach
Harvesting and injection are performed under local anesthesia or IV sedation, and results tend to appear gradually over 4-12 weeks as regeneration progresses. Autologous cells from your own bone marrow · Risk of rejection tends to be low · Performed under local anesthesia or IV sedation · Results appear gradually
We explain the possibilities and limitations of autologous cell treatment in a balanced way.
Because autologous cells obtained from your own bone marrow are used, the risk of rejection tends to be low. Results and responses vary from person to person, so we assess them together during your clinical consultation.
Bone marrow is one of the longest-studied sources of stem cells in the human body, and BMSCs are known to have multilineage differentiation potential and a long record of clinical research data. They play a supportive role in addressing recovery of relatively deep tissue environments.
Because autologous cells obtained from your own bone marrow are used, the risk of rejection tends to be low. However, temporary pain or bruising may occur at the harvesting site, so we explain this thoroughly during your consultation.
Although it draws on a source with a long history of research data, it is not a cure-all for every situation. We first determine whether it suits your condition and goals, and we explain both the significance and the limitations of autologous cells.
NOTICE
PROCEDURE DATA
Treatment Overview
FOR WHOM
Consider a Consultation If
04 Recommended Cases
Doctor's Note
Bone marrow is a source of stem cells backed by a long history of research data, but bone marrow stem cell treatment is not a cure-all for every situation. We first need to determine whether it suits your condition and goals. Rather than overstating the possibilities of regenerative treatment, my principle is to speak candidly about the significance and limitations of autologous cells.
PROCEDURE FLOW
01
PHASE I
We review your health and goals and determine whether autologous cell treatment is suitable for you.
02
PHASE II
Bone marrow is harvested under local anesthesia or IV sedation.
03
PHASE III
The harvested bone marrow is concentrated and purified into bone marrow aspirate concentrate (BMAC).
04
PHASE IV
The concentrate is precisely injected into the target area, and we guide you through the recovery process and aftercare.
FREQUENTLY ASKED
We have compiled the questions patients ask most often before a consultation.
6F #601, 599-4 Sinsa-dong, Gangnam-gu, Seoul
(No lunch break on weekends and public holidays) *Dr. Won-Suk Kook is not available on the 1st and 3rd Saturdays of each month.
Parking Information Parking is available in the building. 1 hour of free parking
Subway 5-minute walk from Exit 3 of Apgujeong Station on Line 3 (right next to the 14-story CGV building at Exit 3)
